Predictive Oncology Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Frequently asked questions
To buy Predictive Oncology Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Predictive Oncology Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Predictive Oncology Inc. is POAI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Predictive Oncology Inc. has its primary listing on NASDAQ (Small cap). You can trade Predictive Oncology Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Predictive Oncology Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Predictive Oncology Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Predictive Oncology Inc..